(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GXSTRANDS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

GXSTRANDS

ST13

US500000098165871

Class

5, 42

Filing

98165871

Registration

7675264

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

17

Latest update

02/04/2025

Classification

Registered

Trademark type

Word

Nice classes

5, 42

Filing date

09/05/2023

Registration date

02/04/2025

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/04/2025

Last transaction

02/04/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

27

Owner location

PLANEGG, DE

Examiner

VAGHANI, MAYUR C

Law office

N60

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

CPTX GMBH
capsitec GmbH

Representatives

Catherine Parrish Lake DORSEY & WHITNEY LLP

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationsDNAsynthetic DNA and single-strand DNA for use in the fields of gene therapygene editingcell therapycancer therapyvirus productionDNA-vaccinationgene transferimmunotherapy; Medicine comprised of DNA for gene therapygene editingcell therapycancer therapyvirus productionDNA-vaccinationgene transferimmunotherapy

Class 42

Research and development of customised DNA; medical and pharmacological research and consultancy services in the field of DNA

Publications

History of USPTO decisions and trademark events.

17 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/04/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/04/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/17/2024

PUBO

PUBLISHED FOR OPPOSITION

12/17/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/11/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/21/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/24/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/24/2024

ALIE

ASSIGNED TO LIE

10/24/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/18/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/18/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/01/2024

GNRT

NON-FINAL ACTION E-MAILED

05/01/2024

CNRT

NON-FINAL ACTION WRITTEN

05/01/2024

DOCK

ASSIGNED TO EXAMINER

05/01/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/28/2023

NWAP

NEW APPLICATION ENTERED

09/08/2023

Continuous trademark protection

Get notified about every new filing that threatens GXSTRANDS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.